• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Lacidipine

Lacidipine

Product ID L0108
Cas No. 103890-78-4
Purity ≥98%
Product Unit SizeCostQuantityStock
10 mg $73.50 In stock
50 mg $236.30 In stock
250 mg $288.80 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Lacidipine is a third-generation dihydropyridine calcium channel blocker that has a demonstrated effectiveness against hypertension. It has been shown to have a preventative effect on myocardial hypertrophy and remodeling in male spontaneously hypertensive rats. In patient-derived Gaucher’s disease fibroblasts, lacidipine has been found to enhance folding, trafficking, and activity of mutated glucocerebrosidase variants. It has been observed to function as a proteostasis regulator and to rescue L444P GC folding with considerably high efficiency by upregulating BiP expression. In addition to blocking L-type Ca2+ channels on the plasma membrane, it has been found to block Ryanodine receptors on the endoplasmic reticulum membrane. It has been shown to activate each of the three arms of the unfolded protein response signal transduction cascade and yet to prevent apoptosis induction, thereby promoting cell survival. Furthermore, lacidipine has been shown to possess antibacterial activity against various organisms, including Vibrio cholerae 569B cells in experimental rabbit ileal loops.

Product Info

Cas No.

103890-78-4

Purity

≥98%

Formula

C26H33NO6

Formula Wt.

455.55

Chemical Name

diethyl 2,6-dimethyl-4-[2-[(E)-3-[(2-methylpropan-2-yl)oxy]-3-oxoprop-1-enyl]phenyl]-1,4-dihydropyridine-3,5-dicarboxylate

IUPAC Name

Diethyl 2,6-dimethyl-4-(2-{(1E)-3-[(2-methyl-2-propanyl)oxy]-3-oxo-1-propen-1-yl}phenyl)-1,4-dihydro-3,5-pyridinedicarboxylate

Synonym

Lacipil, Motens, GR-43659X

Solubility

DMSO 91 mg/mL; Water <1 mg/mL

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

L0108 MSDS PDF

Info Sheet

L0108 Info Sheet PDF

References

Ge Y, Li G, Liu B, et al. The Protective Effect of Lacidipine on myocardial Remodeling Is Mediated by the Suppression in Expression of GPR78 and CHOP in Rats. Evid Based Complement Alternat Med. 2015; 2015: 945076. PMID: 25688281.

Wang F, Chou A, Segatori L. Lacidipine Remodels Protein Folding and Ca2+ Homeostasis in Gaucher’s Disease Fibroblasts: A Mechanism to Rescue Mutant Glucocerebrosidase. Chem Biol. 2011 Jun 24; 18(6):766-76. PMID: 21700212.

Wang F, Segatori L. Remodeling the Proteostasis Network to Rescue Glucocerebrosidase Variants by Inhibiting ER-Associated Degradation and Enhancing ER Folding. PLoS One. 2013 Apr 19; 8(4):e61418. PMID: 23620750.

Dasgupta A, Dastidar S, Antibacterial & antitoxic effects of the cardiovascular drug lacidipine in an animal model. Indian J Med Res. 2012 Jun; 135(6): 913-916. PMID: 22825612.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • G7241

    GSK-461364

    PLK1 inhibitor.

    ≥99%
  • D324094

    Diclofenac Related Compound A

    Impurity of diclofenac

    ≥98%
  • D183736

    19-O-Desmethoxy rapamycin

    Fermentation impurity

    ≥94%
  • D183740

    Desoxypipradrol

    NDRI inhibitor

    ≥98%
  • T1968

    Terpinen-4-ol

    Monoterpene found in various plant sources.

    ≥98%
  • P7219

    Pseudolaric Acid B

    Diterpene acid found in Pseudolarix kaempferi.<...

    ≥98%
  • P1852

    Penicillin G procaine

    Hydrophobic β-lactam; penicillin binding prote...

    ≥98%
  • K0282

    Kavalactones Mixture

    Mixture of kavalactones found in Piper methysti...

    ≥98%
  • R1777

    9-cis-Retinoic Acid

    Vitamin A derivative; RAR and RXR agonist.

    ≥99%
  • P0370

    Paromomycin Sulfate

    Aminoglycoside; protein translation inhibitor, ...

    ≥98%
  • V1600

    VE-821

    ATR inhibitor.

    ≥98%
  • H174466

    Helvolic acid

    A fungal metabolite that inhibits protein synth...

    ≥98%
  • T1952

    Tenuazonic Acid Copper Salt

    Mycotoxin produced by Alternaria; photosynthesi...

    ≥98%
  • F1895

    Fexofenadine Hydrochloride

    Histamine H1 antagonist.

    ≥98%
  • R3221

    3-Formylrifamycin

    Rifamycin derivative, induces pore formation in...

    ≥98%
  • P0246

    Palomid 529

    mTOR inhibitor.

    ≥98%
  • C0145

    Calcitriol

    Active form of vitamin D, regulates dietary Ca2...

    ≥97%
  • B6959

    Bromosporine

    BRD2/4/9 and CECR2 inhibitor.

    ≥99%
  • A1017

    Aceclofenac

    Diclofenac analog, NSAID; COX-2 inhibitor.

    ≥98%
  • A724092

    Asciminib Hydrochloride

    Allosteric inhibitor

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only